Sponsor Dossier
Micro Labs
Sponsor Dossier for Micro Labs. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AMCLAVOX DUO
- Brand: AMOXICILLIN
- Brand: AMOXYCLAV
- Brand: ANAGREDEX
- Brand: ANAGRELIDE
- Brand: ATORSTAT
- Brand: ATORVASTATIN MLPL
- Brand: BTC
About
Micro Labs is an Australian Private Company with ABN 26962236418, registered in Victoria. The entity is active and registered for GST from 2021-11-01.
Portfolio
Micro Labs has 58 brands on the ARTG, of which 12 are indexable and 10 carry a Product Information document. 3 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include AMCLAVOX DUO, AMOXICILLIN, AMOXYCLAV, ANAGREDEX, ANAGRELIDE, ATORSTAT, ATORVASTATIN MLPL, BTC, COCLAVMOX, CYCLACT, CYCLIZ, CYCLIZINE.
Therapeutic focus
— Infectious Disease: 13 brands — Cardiology: 11 brands — Neurology: 10 brands — Endocrinology: 7 brands — Ophthalmology: 5 brands — Psychiatry: 4 brands — Other: 3 brands — Pain Management: 3 brands — Haematology: 2 brands
PBS footprint
3 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.